Rethinking antiviral effects for COVID-19 in clinical studies: early initiation is key to successful treatment

Shoya Iwanami; Keisuke Ejima; Kwang Su Kim; Koji Noshita; Yasuhisa Fujita; Taiga Miyazaki; Shigeru Kohno; Yoshitsugu Miyazaki; Shimpei Morimoto; Shinji Nakaoka; Yoshiki Koizumi; Yusuke Asai; Kazuyuki Aihara; Koichi Watashi; Robin N. Thompson; Kenji Shibuya; Katsuhito Fujiu; Alan S. Perelson; Shingo Iwami; Takaji Wakita

doi:10.1101/2020.05.30.20118067

Rethinking antiviral effects for COVID-19 in clinical studies: early initiation is key to successful treatment

View ORCID ProfileShoya Iwanami, View ORCID ProfileKeisuke Ejima, Kwang Su Kim, Koji Noshita, Yasuhisa Fujita, Taiga Miyazaki, Shigeru Kohno, Yoshitsugu Miyazaki, Shimpei Morimoto, Shinji Nakaoka, Yoshiki Koizumi, Yusuke Asai, Kazuyuki Aihara, Koichi Watashi, Robin N. Thompson, Kenji Shibuya, Katsuhito Fujiu, Alan S. Perelson, Shingo Iwami, Takaji Wakita

doi: https://doi.org/10.1101/2020.05.30.20118067

Shoya Iwanami

1Department of Biology, Faculty of Sciences, Kyushu University, Fukuoka, Japan 8190395.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Shoya Iwanami

Keisuke Ejima

2Department of Epidemiology and Biostatistics, Indiana University School of Public Health-Bloomington, IN, USA 47405.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Keisuke Ejima
For correspondence: kejima@iu.edu siwami@kyushu-u.org

Kwang Su Kim

1Department of Biology, Faculty of Sciences, Kyushu University, Fukuoka, Japan 8190395.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Koji Noshita

1Department of Biology, Faculty of Sciences, Kyushu University, Fukuoka, Japan 8190395.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yasuhisa Fujita

1Department of Biology, Faculty of Sciences, Kyushu University, Fukuoka, Japan 8190395.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Taiga Miyazaki

3Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan 852-8501.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Shigeru Kohno

4Nagasaki University, Nagasaki, Japan 852-8521.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yoshitsugu Miyazaki

5Department of chemotherapy & mycoses, and Leprosy Research Ctr., National Institute of Infectious Diseases, Tokyo, Japan 3320012.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Shimpei Morimoto

6Institute of Biomedical Sciences, Nagasaki University, Japan 852-8501

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Shinji Nakaoka

7Faculty of Advanced Life Science, Hokkaido University, Sapporo, Japan 060-0808.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yoshiki Koizumi

8National Center for Global Health and Medicine, Tokyo, Japan 1628655.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yusuke Asai

9Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan 162-8655.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kazuyuki Aihara

10International Research Center for Neurointelligence, The University of Tokyo Institutes for Advanced Study, The University of Tokyo, Tokyo, Japan.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Koichi Watashi

11Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan 1628640.

12MIRAI, JST, Saitama, Japan 3320012.

13Department of Applied Biological Science, Tokyo University of Science, Noda, Japan 2788510.

14Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan 6068507.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Robin N. Thompson

15Christ Church, University of Oxford, Oxford OX1 1DP, UK.

16Mathematical Institute, University of Oxford, Oxford OX2 6GG, UK.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kenji Shibuya

17Institute for Population Health, King’s College London, London SE1 1UL, UK.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Katsuhito Fujiu

18Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan 1138655.

19Department of Advanced Cardiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan 1138655.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Alan S. Perelson

20Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM 87545, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Shingo Iwami

1Department of Biology, Faculty of Sciences, Kyushu University, Fukuoka, Japan 8190395.

12MIRAI, JST, Saitama, Japan 3320012.

21Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Kyoto 6068501, Japan.

22NEXT-Ganken Program, Japanese Foundation for Cancer Research (JFCR), Tokyo 1358550, Japan.

23Science Groove Inc., Fukuoka 8100041, Japan.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: kejima@iu.edu siwami@kyushu-u.org

Takaji Wakita

11Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan 1628640.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Abstract
Full Text
Info/History
Metrics
Data/Code
Preview PDF

Data Availability

The data examined in our manuscript were extracted from the published studies of SARS-CoV-2. We do not have the right to publicize the data, but we have cited those papers in the manuscript.

View the discussion thread.

PreviousNext

Posted June 03, 2020.

Download PDF

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Rethinking antiviral effects for COVID-19 in clinical studies: early initiation is key to successful treatment

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Rethinking antiviral effects for COVID-19 in clinical studies: early initiation is key to successful treatment

Shoya Iwanami, Keisuke Ejima, Kwang Su Kim, Koji Noshita, Yasuhisa Fujita, Taiga Miyazaki, Shigeru Kohno, Yoshitsugu Miyazaki, Shimpei Morimoto, Shinji Nakaoka, Yoshiki Koizumi, Yusuke Asai, Kazuyuki Aihara, Koichi Watashi, Robin N. Thompson, Kenji Shibuya, Katsuhito Fujiu, Alan S. Perelson, Shingo Iwami, Takaji Wakita

medRxiv 2020.05.30.20118067; doi: https://doi.org/10.1101/2020.05.30.20118067

Share This Article: